Laboratorios Farmaceuticos Rovi, S.A. (LABFF) Comparison with companies in other sectors?

Laboratorios Farmaceuticos Rovi, S.A. has a share price of 51.15M. You can analyze Laboratorios Farmaceuticos Rovi, S.A. (LABFF) competitors across different market sectors through stock heatmaps.

What are LABFF's NET and operating margins?

Laboratorios Farmaceuticos Rovi, S.A. (LABFF) operating margin is around 0.27, and net profit margin is approximately 0.21 as of the latest reports.

In what way does LABFF's earnings per share (EPS) trend reflect its financial momentum?

Laboratorios Farmaceuticos Rovi, S.A. (LABFF) EPS is 3.13 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Laboratorios Farmaceuticos Rovi, S.A. is 28.95, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Laboratorios Farmaceuticos Rovi, S.A.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Laboratorios Farmaceuticos Rovi, S.A. like P/E which is 18.86, P/B which is 6.69, and PEG which is 14.59. Compare them with sector averages to evaluate if the stock is priced fairly.

Laboratorios Farmaceuticos Rovi, S.A.

LABFF•PNK

Healthcare

Biotechnology

$90.61

$0.00(0.00%)

Fundamental Analysis of Laboratorios Farmaceuticos Rovi, S.A. (LABFF)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$3.13

P/E Ratio

28.95

ROE

0.38%

Net Margin

0.21%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$4.63B

Shares OutstandingTotal number of shares issued

$51.15M

Book Value/ShareNet worth per share

$11.72

Revenue/ShareAnnual revenue per share

$19.61

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$3.13

Net MarginNet income as percentage of revenue

20.86%

Operating MarginOperating income as percentage of revenue

27.26%

ROEReturn on shareholders' equity

38.26%

ROAReturn on total assets

25.70%

ROCEReturn on capital employed

39.75%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$1.57

Cash/ShareCash and equivalents per share

$0.57

FCF YieldFree cash flow as percentage of market cap

2.03%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$0.93

Dividend YieldAnnual dividend as percentage of stock price

1.21%

Financial Ratios Analysis data is not available for LABFFFinancial Ratios Analysis details for LABFF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for LABFFSector Benchmarking details for LABFF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Laboratorios Farmaceuticos Rovi, S.A. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Laboratorios Farmaceuticos Rovi, S.A.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Laboratorios Farmaceuticos Rovi, S.A.'s unique business strengths and challenges.

Key Financial Metrics for Laboratorios Farmaceuticos Rovi, S.A.

For Laboratorios Farmaceuticos Rovi, S.A., essential financial indicators include EPS 3.13, PE 28.95, and ROE 0.38. These key ratios reveal insights into Laboratorios Farmaceuticos Rovi, S.A.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Laboratorios Farmaceuticos Rovi, S.A. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Laboratorios Farmaceuticos Rovi, S.A.

Metrics like Net Margin 20.86% and ROA 25.70% shed light on how well Laboratorios Farmaceuticos Rovi, S.A. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Laboratorios Farmaceuticos Rovi, S.A. can sustain its operations and continue growing in the future.

Valuation and Market Position of Laboratorios Farmaceuticos Rovi, S.A.

Using ratios such as P/B Ratio 6.69 and PEG Ratio 14.59, investors can assess whether Laboratorios Farmaceuticos Rovi, S.A. is appropriately valued based on its financials and growth potential. These figures, combined with Laboratorios Farmaceuticos Rovi, S.A.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Laboratorios Farmaceuticos Rovi, S.A.

Financial health indicators, such as Debt/Equity Ratio - and Cash Flow $1.57, provide a snapshot of Laboratorios Farmaceuticos Rovi, S.A.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Laboratorios Farmaceuticos Rovi, S.A., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Laboratorios Farmaceuticos Rovi, S.A.

Investing in Laboratorios Farmaceuticos Rovi, S.A. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Laboratorios Farmaceuticos Rovi, S.A. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;